Quantcast

Elsevier Announces the Launch of Open Access Journal: Bone Reports

July 16, 2014

OXFORD, England, July 16, 2014 /PRNewswire/ –

Elsevier [http://www.elsevier.com ], world-leading provider of scientific, technical
and medical information products and services, is pleased to announce the launch of a new
open access journal: Bone Reports [http://www.journals.elsevier.com/bone-reports ].

As sister publication to the highly reputable journal Bone
[http://www.journals.elsevier.com/bone ], Bone Reports will serve as an interdisciplinary
forum for the rapid publication of research articles and case reports across basic,
translational and clinical aspects of bone and mineral metabolism. The journal welcomes
studies replicating or failing to replicate previous studies.

Editor-in-Chief for Bone Reports, Professor Peter R. Ebeling, Monash University, and
also Senior Editor for sister journal Bone, commented, “I am excited to serve as
Editor-in-Chief of Bone Reports, which fulfills a critical and current need to enhance
research by publishing reproducibility studies and null findings.”

“I am delighted to partner with Professor Ebeling,” said Editor-in-Chief of Bone,
Professor Sundeep Khosla, Mayo Clinic, explaining that, “with the launch of Bone Reports
authors now have a new option to publish solid science related to bone metabolism. I
believe the two journals will complement each other very well and expand the scope of
content we can provide to our readers.”

For more information or to submit an article, go to:

http://www.journals.elsevier.com/bone-reports

About Open Access Publishing at Elsevier

Elsevier has been providing open access publishing options since 2005. Today,
researchers can choose to publish open access in over 1,600 established peer-reviewed
journals as well as over 100 full open access journals and these numbers will continue to
grow rapidly. All of Elsevier’s open access publications have been peer reviewed, ensuring
that the broader community not only reads the latest research but that it is factual,
original and of the highest quality and ethical standards. For more information about
Elsevier’s open access program, visit http://www.elsevier.com/openaccess.

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance
of science, health, and technology professionals, empowering them to make better
decisions, deliver better care, and sometimes make groundbreaking discoveries that advance
the boundaries of knowledge and human progress. Elsevier provides web-based, digital
solutions – among them ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Elsevier Research Intelligence
[http://www.elsevier.com/online-tools/research-intelligence ] and ClinicalKey
[https://www.clinicalkey.com ] – and publishes nearly 2,200 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and over 25,000 book titles,
including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading provider of professional information solutions in the Science, Medical,
Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed
Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange),
RUK and ENL (New York Stock Exchange).

        Media contact
        Joanna Cipolla
        Elsevier
        +44(0)18-65-84-34-77
        j.cipolla@elsevier.com

SOURCE Elsevier


Source: PR Newswire



comments powered by Disqus